FDAFDA · Food and drugs·Recall number D-0005-2022
Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01
Published October 13, 2021 · Recall initiated: September 2, 2021
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect Instructions
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- RISING PHARMACEUTICALS
- Distributor
- to be entered
- Lot
- Lot # CB21024, Exp 2/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.